Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis-Reference-Cited by-同舟云学术

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis

Published:2015-04-02 Issue:4 Volume:10 Page:e0122048
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aeinehband Shahin,Lindblom Rickard P. F.,Al Nimer Faiez,Vijayaraghavan Swetha,Sandholm Kerstin,Khademi Mohsen,Olsson Tomas,Nilsson Bo,Ekdahl Kristina Nilsson,Darreh-Shori Taher,Piehl Fredrik

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Multiple sclerosis;A Compston;Lancet,2008

2. Natural history of multiple sclerosis: a unifying concept;C Confavreux;Brain,2006

3. Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis;EC Tallantyre;Mult Scler,2010

4. Evidence for a two-stage disability progression in multiple sclerosis;E Leray;Brain,2010

5. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis;HL Weiner;J Neurol,2008

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis;Neurology Neuroimmunology & Neuroinflammation;2024-07

2. The complement system in neurodegenerative diseases;Clinical Science;2024-03

3. Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes;Journal of Neuroinflammation;2024-02-17

4. Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes;2023-10-19

5. Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis;Frontiers in Cellular Neuroscience;2023-03-22